OX-24

Human Factor H

Mouse x Mouse hybridoma

The hybridoma line OX-24 was developed by immunizing BALB/c mice with Factor H followed by fusion of spleen cells with NS0 mouse myeloma cells. The antibody was shown to detect the human complement control protein, Factor H. OX-24, which is also known as MRC-OX24 was reported to increase cofactor activity of Factor H in Factor I-mediated cleavage of soluble C3b. The antibody inhibited the binding of radioactive-labelled Factor H to surface-bound C3b. OX-23 (Sigma Catalogue number. 00010402) was shown to decrease this inhibition.

RPMI 1640 (R0883) + 2mM Glutamine (G7513) + 10% FBS / FCS (F2442)

Maintain cultures between 3-9 x 100,000 cells/ml; 5% CO₂; 37°C.

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.

This cell line is part of the European Collection of Authenticated Cell Cultures (ECACC), an international repository managed by the United Kingdom Health Security Agency (UKHSA). Use of this product by commercial organizations may require a license agreement. Commercial customers will be contacted by cellscreening@merckgroup.com to provide further information after the order request is submitted. Any other use of these products is prohibited without the express written permission of UKHSA. Inquiries regarding authorized use of this cell line or its genomic DNA may be directed to culturecollections@ukhsa.gov.uk.

This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form.